Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes

Neurobiology of Aging

Volumn 34, Issue 6, 2013, Pages 1680-1686

  Delvaux, Elaine ^a   Bentley, Karen ^b   Stubbs, Victoria ^b   Sabbagh, Marwan ^a   Coleman, Paul D ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; APP; Brain; Differential processing; Peripheral blood leukocytes

Indexed keywords

ADAM10 ENDOPEPTIDASE; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; BETA SECRETASE 2; NICASTRIN; PRESENILIN 1;

ALZHEIMER DISEASE; ARTICLE; BRAIN; CELL NUCLEUS; CELL SPECIFICITY; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEUKOCYTE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BIOLOGICAL MARKERS; BRAIN; HUMANS; LEUKOCYTES, MONONUCLEAR; PARKINSON DISEASE;

EID: 84875271668     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.12.004     Document Type: Article

References (40)

1. Borroni B., Agosti C., Marcello E., Di Luca M., Padovani A. Blood cell markers in Alzheimer disease: amyloid precursor protein form ratio in platelets. Exp. Gerontol. 2010, 45:53-56.
2. Buoso E., Lanni C., Schettini G., Govoni S., Racchi M. Beta-amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain. Pharmacol. Res. 2010, 62:308-317.
3. Buxbaum J.D., Thinakaran G., Koliatsos V., O'Callahan J., Slunt H.H., Price D.L., Sisodia S.S. Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J. Neurosci. 1998, 18:9629-9637.
4. Cao X., Sudhof T.C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 2001, 293:115-120. [erratum in 2001;293:1436].
5. Cao X., Sudhof T.C. Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J. Biol. Chem. 2004, 279:24601-24611.
6. Gervais F.G., Xu D., Robertson G.S., Vaillancourt J.P., Zhu Y., Huang J., LeBlanc A., Smith D., Rigby M., Shearman M.S., Clarke E.E., Zheng H., Van Der Ploeg L.H.T., Ruffolo S.C., Thornberry N.A., Xanthoudakis S., Zamboni R.J., Roy S., Nicholson D.W. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation. Cell 1999, 97:395-406.
7. Gouras G.K., Almeida C.G., Takahashi R.H. Intraneuronal abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol. Aging 2005, 26:1235-1244.
8. Gygi S.P., Rochon Y., Franza B.R., Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 1999, 19:1720-1730.
9. Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 2007, 8:101-112.
10. Hampel H., Shen Y., Walsh D.M., Aisen P., Shaw L.M., Zetterberg H., Trojanowski J.Q., Blennow K. Biological markers of amyloid beta-related mechanisms in Alzheimer's disease. Exp. Neurol. 2010, 223:334-346.
11. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
12. Holtzman D.M. CSF biomarkers for Alzheimer's disease: current utility and potential future use. Neurobiol. Aging 2011, 32:S4-S9.
13. Jenkins J.K., Suwannaroj S., Elbourne K.B., Ndebele K., McMurray R.W. 17-β-Estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A. Int. Immunopharm. 2001, 1:1897-1911.
14. Jonsson T., Atwal J.K., Steinberg S., Snaedal J., Jonsson P.V., Bjornsson S., Stefansson H., Sulem P., Gudgjartsson D., Maloney J., Hoyte K., Gustafson A., Liu Y., Lu Y., Bhangale T., Graham R.R., Huttenlocher J., Bjornsdottir G., Andreassen O.A., Jonsson E.G., Palotie A., Behrens T.W., Magnusson O.T., Kong A., Thorsteinsdottir U., Watts R.J., Stefansson K. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 2012, 488:96-99.
15. Jung S.S., Gauthier S., Cashman N.R. β-amyloid precursor protein is detectable on monocytes and is increased in Alzheimer's disease. Neurobiol. Aging 1999, 20:249-257.
16. Kimberly W.T., Zheng J.B., Guenette S.Y., Selkoe D.J. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J. Biol. Chem. 2001, 276:40288-40292.
17. Konig G., Monning U., Czech C., Prior R., Banati R., Schreiter-Gasser U., Bauer J., Masters C.L., Beyreuther K. Identification and differential expression of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells. J. Biol. Chem. 1992, 267:10804-10809.
18. Li Q.X., Fuller S.J., Beyreuther K., Masters C.L. The amyloid precursor protein of Alzheimer disease in human brain and blood. J. Leukocyte Biol. 1999, 66:567-574.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
20. Lublin A.L., Gandy S. Amyloid-beta oligomers: possible roles as key neurotoxins in Alzheimer's disease. Mt. Sinai J. Med. 2010, 77:43-49.
21. Mayeux R., Schupf N. Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants. Neurobiol. Aging 2011, 32:S10-S19.
22. Mohamed A., Posse de Chaves E. Aβ internalization by neurons and glia. Int. J. Alzheimers Dis. 2011, 2011:127984.
23. Mukaetova-Ladinska E.B., Abdel-All Z., Dodds S., Andrade J., Alves da Silva J., Kalaria R.N., O'Brien J.T. Platelet immunoglobulin and amyloid precursor protein as potential peripheral biomarkers for Alzheimer's disease: findings from a pilot study. Age Ageing 2012, 41:408-412.
24. Muller T., Meyer H.E., Egensperger R., Marcus K. The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer's disease. Prog. Neurobiol. 2008, 85:393-406.
25. Muresan Z., Muresan V. A phosphorylated, carboxy-terminal fragment of beta-amyloid precursor protein localizes to the splicing factor compartment. Hum. Mol. Genet. 2004, 13:475-488.
26. Ohkawara T., Nagase H., Koh C.S., Nakayama K. The amyloid precursor protein intracellular domain alters gene expression and induces neuron-specific apoptosis. Gene 2011, 475:1-9.
27. Palop J.J., Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 2010, 13:812-818.
28. Prakash A., Levy D.E. Regulation of IRF7 through cell type-specific protein stability. Biochem. Biophys. Res. Commun. 2006, 342:50-56.
29. Roher A.E., Esh C.L., Kokjohn T.A., Castano E.M., Van Vickle G.D., Kalback W.M., Patton R.L., Luehrs D.C., Daugs I.D., Kuo Y.M., Emmerling M.R., Soares H., Quinn J.F., Kaye J., Connor D.J., Silverberg N.B., Adler C.H., Seward J.D., Beach T.G., Sabbagh M.N. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement 2009, 5:18-29.
30. Sandbrink R., Masters C.L., Beyreuther K. Beta A4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons. J. Biol. Chem. 1994, 269:1510-1517.
31. Sandbrink R., Masters C.L., Beyreuther K. APP gene family. Alternative splicing generates functionally related isoforms. Ann. N. Y. Acad. Sci. 1996, 777:281-287.
32. Selkoe D.J., Podlisny M.B., Joachim C.L., Vickers E.A., Lee G., Fritz L.C., Oltersdorf T. β-amyloid precursor protein of Alzheimer disease occurs as 110-to 135-kilodalton membrane associated proteins in neural and nonneural tissues. Proc. Natl. Acad. Sci. U. S. A 1988, 85:7341-7345.
33. Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Selkoe D.J., Sabatini B.L. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 2007, 27:2866-2875.
34. Shimada H., Ataka S., Tomiyama T., Takechi H., Mori H., Miki T. Clinical course of patients with familial early-onset Alzheimer's disease potentially lacking senile plaques bearing the E693Δ mutation in amyloid precursor protein. Dement. Geriatr. Cogn. Disord. 2011, 32:45-54.
35. Stieler J., Grimes R., Weber D., Gartner W., Sabbagh M., Arendt T. Multivariate analysis of differential lymphocyte cell cycle activity in Alzheimer's disease. Neurobiol. Aging 2012, 33:234-241.
36. Sultana R., Mecocci P., Mangialasche F., Cecchetti R., Baglioni M., Butterfield D.A. Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder. J. Alzheimers Dis. 2011, 24:77-84.
37. Takeda S., Sato N., Rakugi H., Morishita R. Plasma beta-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease. Mol. Biosyst. 2010, 6:1760-1766.
38. von Rotz R.C., Kohli B.M., Bosset J., Meier M., Suzuki T., Nitsch R.M., Konietzko U. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J. Cell Sci. 2004, 117:4435-4448.
39. Walsh D.M., Klyubin I., Shankar G.M., Townsend M., Fadeeva J.V., Betts V., Podlisny M.B., Cleary J.P., Ashe K.H., Rowan M.J., Selkoe D.J. The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention. Biochem. Soc. T. 2005, 33:1087-1090.
40. Zhao M., Su J., Head E., Cotman C. Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease. Neurobiol. Dis. 2003, 14:391-403.